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Summary: Clinical effects of spa therapy were examined in 150 patients with asthma
in relation tobronchial hyperresponsiveness and patient age. 1. The efficacy rate of
spa therapy was larger as the patient age was higher: the rate was 73.3% in patients
under age 49, 81.8% in those between the ages of 50 and 59, 86.4% in those between
the ages of 60 and 69, and 90.6% in those over age 70. The mean of efficacy rates was
83.3% in all subjects.
2. The bronchial hyperresponsiveness (BH) was lower as patient age was higher: the
BH in patients between the ages of 60 and 69 and in those over age 70 was signifi-
cantly lower compared to the BH in those under age 49 (p<O.OOl).
3. Clinical effects of spa therapy tended to be lower in patients with increased
bronchial hyperresponsiveness. The bronchial hyperresponsiveness showed a tendency to
decrease after spa therapy in whom the therapy was effective, however, the BH did not
change in patients with slight or no efficacy during spa therapy.
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Introduction
In recent years, the number of elderly patients
with asthma has been increasing. Bronchial
asthma is a disease characterized by bronchial
hyperreactivity .to various stmuli, in which
IgE-mediated allergic reaction mainly partici-
pate even in elderly patients with asthma as
a major factor affecting the pathophysiology
of the airways!). The IgE-mediated allergy
has been reported to change qualitively and
quantatively with aging2~) Our previous stud-
ies have shown that bronchial reactivity to
methacholine and the release of histamine
from leucocytes tend to decrease with aging6!
It has been shown that spa therapy is
effective in bronchial asthma: the therapy
improves clinical symptoms'), and ventilatory
function~~) in patients with asthma, particu-
larly the disease accompanied by hypersecretion
and bronchiolar obstruction1o• ll ) as the direct
action of the therapy. Bronchial hyperresponsi-
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veness IS improved by spa therapy!2J. The
therapy is also effective for elderly patients
with asthma!3? Furthermore, suppressed func-
tion of adrenocortical glands is also improved
by spa therapy as the indirect action of the
therapy14.!5? However, the efficacy of spa ther-
apy on asthma is affected by several factors
such as patient age, disease severity, and
bronchial hyperresponsiveness. In this study,
the effects of spa therapy on asthma were
discussed in relation to bronchial hyperresponsi-
veness and patient age.
Subjects and Methods
The subjects in this study were 150 patients
(81 females and 69 males) with asthma. Their
mean age was 57.7 years (range 21-77 years).
All subjects were admitted at Misasa Medical
Branch and had complex spa therapy!6J for
1-3 months. The subjects were divided into
three groups according to efficacy of spa
therapy; marked, moderate, and slight or no
efficacy. The efficacy of spa therapy was
evaluated by comparing their symptoms
before and after undergoing spa therapy. Spa
therapy was judged as being effective for
patients whose efficacy was marked and
moderate. The subjects were also classified
into four groups according to their age: 0-49,
50-59, 60-69, and 70+ years.
Bronchial responsiveness to methacholine
before spa therapy was compared with the
value after the therapy. Suppression of bron-
chial hyperresponsiveness. by spa therapy. was
expressed as an improvement rate (IR),
which was calculated as following formula:
improvement rate(IR) =C min of methacholine
after spa therapy/C min before the therapy
+C min after the therapy. Higher value of IR
suggest that spa therapy suppressed bronchial
hyperresponsiveness more strongly.
Bronchial reactivity to methacholine was
examined by a Astograph (TCK6100H, Chest
Co)when the subjects were attack-free. Vari-
ous concentrations of methacholine (49, 98,
195, 390, 781, 1563, 3125, 6250, 12500 ,ug/ml)
were prepared for bronchial challenge accord-
ing to the mE,:lthod used by Chai et al"; An
increase of total respiratory resistance eRrs)
after methacholine inhalation was observed
by the oscillation method. A methacholine
concentration causing a significant increase in
Rrs was assessed as Cmin (minimum concen-
tration). All medications were stopped 12
hours prior to the examination.
The generation of leukotrienes B4 (LTB4)
and C4 (LTC4) by peripheral leucocytes was
assessed by a method previously described!S;
Buffy coat was separated by adding a quar-
ter volume of 6% dextran and followed by
being left 1 hour at room temperature. After
the number of the cells was adjusted to 5xl06
cells/ml in Tris ACM, Ca ionophore A23187
Cl If g) was added to the cell suspension. The
mixed solution was incubated for 15 min at
37°C, and centrifuged at 3000 rpm for 30 min
after the addition of 4 times volume of
pre-chilled ethanol (finally 80% ethanol).
Supernatant was taken into the syringe filter
(Toyo Roshi Co, Japan) ,and dried up to
solid. The solid was dissolved with 250 .ul
of 50% ethanol. The HPLC analysis for LTB4
and LTC4 was performed by a method de-
scribed by Lam et al19J. The results were
expressed as ng/5xl06cells.
Statistically significant differences of the
mean were estimated using the unpaired
Student' t test. A p value of <0.05 was re-
garded as significant.
Results
Figure 1 shows clinical effects of spa ther-
apy in patients with asthma classified by
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Fig. 2. Bronchial hyprresponsiveness to
methacholine III patients with
asthma and patient age. a and b,
p<O.OOl.
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Fig. 3-a. Clinical effects of spa therapy on
patients with asthma under the
age of 49 years in relation to
bronchial hyperresponsiveness
reactivity in those with slight or. no efficacy.
Bronchial hyperresponsiveness decreased
after spa therapy in patients with marked
spa therapy on
III relation to
Clinical effects of
bronchial asthma
patient age.
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Fig. 1.
age. The efficacy rate of spa therapy III all
subjects was 83.3%. The effects of spa
therapy was larger in patients over the age
of 70 (90.6%) than in those under the age of
49 (73.3%). Bronchial hyperresponsiveness
(BH) to methacholine tended to decrease with
aging. The BH in patients between the ages
of 60 and69 (p<O.OOl) and in those over age
70 (p<O.OOl) was significantly lower than
the reactivity in those under age 49 (Fig. 2).
Any significant correlations were not ob-
served between clinical effects of spa therapy
and bronchial hyperresponsiveness in patients
under age 49 (Fig. 3-a) and in those between
the ages of 50 and 59 (Fig. 3-b) , however,
bronchial hyperresponsiveness was larger III
patients· with slight or no efficacy than in
those with moderate efficacy in both age
groups. The bronchial hyperresponsiveness
was generally low in patients between the
ages of 60 and 69 (Fig. 3-c) and over age 70
(Fig. 3-d), and the reactivity in patients with
moderate efficacy was lower than the
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Fig. 3- b. Clinical effects of spa therapy on
patients with asthma between the
ages of 50 and 59 years in relation
to bronchial hyperresponsiveness
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Fig. 3- c. Clinical effects of spa therapy on
patients with asthma between the
ages of 60 and 69 years in relation
to bronchial hyperresponsiveness
efficacy, compared with
before the therapy. The
OR) (expressed by Cmin
the initial value
improvement rate
of methacholine
Fig. 4-a. Comparison of bronchial hyperrespon-
Slveness before (B) and after spa
therapy (A) in asthmatics with
marked efficacy In relation to pa-
tient age. Improvement rate (IR) :
0.86 (0 -49 years), 0.78 (50-59 year
s) , 0.65 (60-69 years), and 0.65
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after spa therapy/Cmin before the therapy
+ C Cmin after the therapy) was considera-
bly high from 0.65 to 0.86 in patients with
marked efficacy. In these patients, the IR
was higher in younger subjects under age 59
than in subjects between ages of 60 and 69
and over age 70 (Fig. 4-a). In patients with
moderate efficacy of spa therapy, the IR was
from 0.58 to 0.79, which was relatively low
compared with the values in patients with
marked efficacy. The IR in these patients
was higher in subjects between ages of 60 and
69 and over age 70, compared with the value
in younger subjects under age 59 (Fig. 4-b).
The IR of bronchial hyperresponsivness by
spa therapy was very low from 0.50 to 0.58
in patients with slight or no efficacy. The
IR was not different among four age groups
(Fig. 4-c).
The generation of LTB4 by leucocytes was
higher in patients with marked efficacy and
with moderate efficacy than in those with
Fig. 5. Clinical effects of spa therapy and
generation of leukotriene B 4 by
peripheral leucocytes in patients with
asthma.
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Fig. 4- b. Comparison of bronchial hyperrespon-
siveness before (B) and after spa
therapy (A) in asthmatics with
moderate efficacy in relation to
patient age. Imprevement rate OR)
: 0.58 (0 -49 years), 0.62 (50-59 ye
ars) , 0.79 (60-69 years) ,and 0.67
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Fig. 4- C. Comparison of bronchial hyperrespon-
siveness before (B) and after spa
therathy. (A) in· asthmatics with
slight or no efficacy in relation to
patient age. Improvement rate OR)
: 0.59 (0 -49 years), 0.57 (50-59 ya
ers) , -0.53 (60-69 years), and 0.50
(70+years)
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Discussion
Fig. 6. Clinical effects of spa therapy and
generation of leukotriene C 4 by
peripheral leucocytes -Ill patients
with asthma.
slight or no efficacy, however,these differ-
ences were not significant (Fig. 5). The mean
value in the generation of LTC4 was not
different among three groups divided by spa
efficacy, however, some of patients with
marked and moderate efficacy showed higher
value in the LTC4 generation (Fig. 6).
types, spa therapy is more effective in pa-
tients with type Ib and H than in those with
type Ian . Clinical effects of spa therapy on
asthma are comprised of the direct action
for airways and the indirect action for
adrenocortical glandsl4. 15), autonomic nerve
system32 ), and so on. Furthermore, spa ther-
apy is shown to have suppressive action of
oronchial hyperresponsivenessIO ), which is one
of the characteristics of asthma. It has been
shown that spa therapy is also effective for
asthma patients in the elderlyl3: In the present
study, the efficacy of spa therapy on bronchial
asthma was examined in relation to bronchial
hyperresponsiveness and patient age.
Clinical effects of spa therapy on asthma
were to a certain extent related to patient
age. In general, spa efficacy was larger as
patient age was higher: efficacy rate (73.3%)
in patients under age 49 was lower than the
rate (90.6%) in those over age 70. Bronchial
hyperresponsiveness to methacholine decreased
as patient age was higher: the bronchial
hyperresponsiveness inpatients over age 70
and in those between the ages of 60 and 69
was significantly lower than the responsive-
ness in those under _age 49. These results
demonstrated that spa therapy was more
effective in older patients with low bronchial
responSIveness.
A correlation between bronchial hyperrespon-
siveness and spa efficacy was observed in all
age groups: spa efficacy was lower in patients
with increased bronchial hyperresponsiveness.
However, bronchial hyperresponsiveness tended
to decrease after spa therapy in asthma
patients, particularly in those with marked
and moderate efficacy of spa therapy. In the
patients with marked efficacy, improvement
rate (IR) by spa therapy, expressed by the
formula erR = C min of methacholine after
,
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Spa therapy has been performed for the
treatment of patients with asthma and chronic
obstructive pulmonary disease CC 0 P D) ID) •
Bronchial asthma can be classified into three
types according to clinical symptoms :
la. simple bronchoconstriction type, lb.
bronchoconstriction + hypersecretion type, and
H. bronchiolar obstruction type21-23?Our previous
studies have demonstrated that spa therapy
is effective for patients with asthma6-l2,24-28)
and those with COPD, particularly pulmonary
emphysema 29-31). Regarding clinical asthma
Spa therapy and bronchial reactivity in asthma 16
spa therapy /Cmin before the therapy +
Cmin after the therapy) was higher in pa-
tients under age 49 (0.86) and in those be-
tween the ages of 50 and 59 (0.78) compared
to the IR in those between the ages of 60 and
69 (0.65) and over age 70 (0.65). The results
might suggest that improvement of bronchial
hyperresponsiveness by spa therapy was lerger
in younger patients with marked efficacy. In
contrast, in patients with moderate efficacy,
the IR was larger in subjects between the
ages of 60 and 69 (0.79) and over age 70
(0.67) in those under age 49 (0.58) and be-
tween the ages of 50 and 59 (0.62). Bron-
chial hyperresponsiveness did not change by
spa therapy in patients with slight and no
efficacy.
In our previous studies showed that spa
therapy was more effective in patients with
increased generation of leukotienes B4 (LTB4)
and C4 (LTC4) by leucocytes23J • However, any
significant correlation between generation of
leukotrienes B4 (LTB4) and C4 (LTC4) by
leucocytes and spa efficacy was not observed
in this study.
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高齢者気管支慌息における気道過敏性と温泉療法
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150例の気管支瑞息症例を対象に,気道過敏性
と年齢との関連のもとに温泉療法の効果が評価さ
れた｡
1.温泉療法では,年齢が高くなるほどその有効
率も高くなると言う傾向が見られ､49才以下
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の症例では73.3%,50-59才の症例では81.8%,
60-69才の症例では86.4%,70才以上では90.6
%であり,全症例の平均有効率は73.3%で
あった｡
2.気道過敏性は,年齢が高くなるほど低下する
傾向が見られ,60-69才および70才以上の症
例の気道過敏性は,49才以下の症例と比べ有
意に低い値を示した(P<0.001)0
3.温泉療法の臨床効果は,気道過敏性が強くな
るにつれて低下する傾向が見られた｡また,
温泉療法の著効例や有効例では,治療により
気道過敏性が低下してくるが､やや有効例や
無効例では,気道過敏性はほとんど変化しな
いことが示された｡
